VFEND

VFEND is a prescription medication developed by Pfizer Inc., an American pharmaceutical company headquartered in New York City. It is an antifungal agent used to treat serious fungal infections, including invasive aspergillosis and candidemia. VFEND is available in various forms, including tablets, oral suspension, and intravenous injection. The manufacturing of VFEND occurs in multiple countries, reflecting Pfizer's global production capabilities. As of 2025, Pfizer Inc. remains the ultimate owner of the VFEND brand, continuing its commitment to providing essential healthcare solutions worldwide.